Roivant Sciences Ownership | Who Owns Roivant Sciences?
Roivant Sciences Ownership Summary
Roivant Sciences is owned by 14.14% institutional investors, 27.68% insiders, and 58.18% retail investors. Qvt financial lp is the largest institutional shareholder, holding 9.10% of ROIV shares. Fidelity Growth Compy Commingled Pl S is the top mutual fund, with 3.59% of its assets in Roivant Sciences shares.
ROIV Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Roivant Sciences | 14.14% | 27.68% | 58.18% |
Sector | Healthcare Stocks | 279.15% | 10.63% | -189.78% |
Industry | Biotech Stocks | 63.94% | 10.67% | 25.38% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Qvt financial lp | 65.79M | 9.10% | $663.86M |
Sb investment advisers (uk) | 61.85M | 8.56% | $624.09M |
Fmr | 49.30M | 6.70% | $583.24M |
Viking global investors lp | 47.81M | 6.50% | $565.59M |
Vanguard group | 44.09M | 5.99% | $521.55M |
Blackrock funding, inc. /de | 42.16M | 5.73% | $498.72M |
Blackrock | 35.37M | 4.41% | $373.86M |
Morgan stanley | 29.33M | 3.65% | $310.02M |
Rubric capital management lp | 17.77M | 2.46% | $179.27M |
State street | 18.44M | 2.30% | $194.94M |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Qvt financial lp | 65.79M | 61.12% | $663.86M |
Patient square capital lp | 12.48M | 52.09% | $125.92M |
Atalaya capital management lp | 1.71M | 40.31% | $18.13M |
Anchorage capital group | 4.83M | 19.50% | $48.76M |
Whitefort capital management, lp | 3.41M | 16.19% | $34.42M |
Tyro capital management | 2.47M | 9.27% | $24.88M |
Stempoint capital lp | 2.58M | 8.29% | $26.02M |
Adar1 capital management | 3.48M | 6.52% | $35.15M |
Tejara capital | 813.55K | 6.30% | $9.62M |
Prosight management, lp | 1.83M | 6.05% | $18.43M |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Ubs group | 5.29M | 0.01% | 4.78M |
Norges bank | 4.43M | 0.01% | 4.43M |
Invesco | 9.52M | 0.02% | 3.16M |
Vanguard group | 44.09M | 0.01% | 2.40M |
Toms capital investment management lp | 5.88M | 2.54% | 1.87M |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Morgan stanley | 29.33M | 0.02% | -6.31M |
Viking global investors lp | 47.81M | 1.83% | -6.29M |
Avoro capital advisors | - | - | -4.65M |
Goldman sachs group | 2.11M | 0.00% | -3.28M |
Bvf inc/il | - | - | -2.74M |
New Positions
Holder | Shares | % Assets | Change | Value |
---|---|---|---|---|
Norges bank | 4.43M | 0.01% | 4.43M | $52.44M |
Cutter capital management, lp | 1.30M | 5.71% | 1.30M | $13.12M |
Sofinnova investments | 1.28M | 0.84% | 1.28M | $12.91M |
Foursixthree capital lp | 850.00K | 2.36% | 850.00K | $8.58M |
Integral health asset management | 600.00K | 0.64% | 600.00K | $6.05M |
Sold Out
Holder | Change |
---|---|
Activest wealth management | -1.00 |
Tfc financial management | -2.00 |
Mv capital management | -13.00 |
Mather group, llc. | -13.00 |
Cornerstone planning group | -27.00 |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Mar 31, 2025 | 15 | -95.41% | 102,194,746 | -81.83% | 14 | 0.23% | 6 | -96.18% | 3 | -97.12% |
Dec 31, 2024 | 293 | -4.87% | 455,984,070 | -19.26% | 61 | 1.05% | 142 | -20.22% | 95 | 35.71% |
Sep 30, 2024 | 306 | 0.66% | 564,022,060 | 3.35% | 76 | 1.39% | 177 | 4.12% | 69 | -14.81% |
Jun 30, 2024 | 303 | 14.34% | 545,755,248 | 3.61% | 67 | 1.57% | 169 | 6.29% | 81 | 24.62% |
Mar 31, 2024 | 265 | 10.88% | 526,729,372 | -2.70% | 65 | 1.60% | 159 | 8.90% | 65 | 22.64% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
Fidelity Growth Compy Commingled Pl S | 24.42M | 3.59% | 674.44K |
Fidelity Growth Compy Commingled Pl O | 21.15M | 2.86% | 439.20K |
Fidelity Growth Company Fund | 17.52M | 2.58% | 623.41K |
Vanguard Total Stock Mkt Idx Inv | 13.76M | 2.02% | 11.18K |
iShares Core S&P Mid-Cap ETF | 13.72M | 2.02% | 7.17K |
Vanguard US Total Market Shares ETF | 14.26M | 2.00% | 14.26M |
Vanguard Small Cap Index | 10.80M | 1.59% | 54.34K |
SPDR® S&P Biotech ETF | 7.21M | 1.06% | -117.95K |
Vanguard Institutional Extnd Mkt Idx Tr | 6.56M | 0.97% | 45.13K |
Invesco S&P MidCap Quality ETF | 6.02M | 0.89% | - |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Jul 21, 2025 | Venker Eric | President & Immunovant CEO | Sell | $1.15M |
Jun 20, 2025 | Venker Eric | President & COO | Sell | $1.15M |
Jun 18, 2025 | Ramaswamy Vivek | - | Sell | $6.47M |
Jun 20, 2025 | Ramaswamy Vivek | - | Sell | $6.61M |
Jun 04, 2025 | Ramaswamy Vivek | - | Sell | $6.21M |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2025 Q3 | - | 1 |
2025 Q2 | - | 11 |
2025 Q1 | - | 7 |
2024 Q4 | - | 8 |
2024 Q3 | - | 12 |
ROIV Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools